AR127140A1 - Método para la generación de estirpes celulares de macrófagos no transformados - Google Patents

Método para la generación de estirpes celulares de macrófagos no transformados

Info

Publication number
AR127140A1
AR127140A1 ARP220102573A ARP220102573A AR127140A1 AR 127140 A1 AR127140 A1 AR 127140A1 AR P220102573 A ARP220102573 A AR P220102573A AR P220102573 A ARP220102573 A AR P220102573A AR 127140 A1 AR127140 A1 AR 127140A1
Authority
AR
Argentina
Prior art keywords
macrophages
pig
transformed
csf
culturing
Prior art date
Application number
ARP220102573A
Other languages
English (en)
Spanish (es)
Inventor
Gyorgy Fejer
Justyna Lopatecka
Original Assignee
Univ Plymouth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2113747.6A external-priority patent/GB202113747D0/en
Priority claimed from GBGB2210102.6A external-priority patent/GB202210102D0/en
Application filed by Univ Plymouth filed Critical Univ Plymouth
Publication of AR127140A1 publication Critical patent/AR127140A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/17—Monocytes; Macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352—Mesenchymal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ARP220102573A 2021-09-27 2022-09-26 Método para la generación de estirpes celulares de macrófagos no transformados AR127140A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2113747.6A GB202113747D0 (en) 2021-09-27 2021-09-27 Method for the generation of non-transformed macrophage cell line
GBGB2210102.6A GB202210102D0 (en) 2022-07-09 2022-07-09 Method for generation of non-transformed macrophage cell line

Publications (1)

Publication Number Publication Date
AR127140A1 true AR127140A1 (es) 2023-12-20

Family

ID=83995013

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220102573A AR127140A1 (es) 2021-09-27 2022-09-26 Método para la generación de estirpes celulares de macrófagos no transformados

Country Status (9)

Country Link
EP (1) EP4408983A1 (https=)
JP (1) JP2024534503A (https=)
KR (1) KR20240067919A (https=)
AR (1) AR127140A1 (https=)
AU (1) AU2022351386A1 (https=)
CA (1) CA3233040A1 (https=)
MX (1) MX2024003500A (https=)
UY (1) UY39959A (https=)
WO (1) WO2023046873A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014012933A1 (en) * 2012-07-16 2014-01-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the generation of non-transformed macrophage cell lines

Also Published As

Publication number Publication date
KR20240067919A (ko) 2024-05-17
EP4408983A1 (en) 2024-08-07
MX2024003500A (es) 2024-04-04
WO2023046873A1 (en) 2023-03-30
CA3233040A1 (en) 2023-03-30
UY39959A (es) 2023-04-14
AU2022351386A1 (en) 2024-04-04
JP2024534503A (ja) 2024-09-20

Similar Documents

Publication Publication Date Title
CO2022011682A2 (es) Método para producir linfocitos citolíticos naturales a partir de células madre pluripotentes
AR111785A2 (es) Método in vitro de producción de eritrocitos
Cordova et al. Development rate and gene expression of IVP bovine embryos cocultured with bovine oviduct epithelial cells at early or late stage of preimplantation development
AU2019268194A1 (en) Cell culture system
AR069956A1 (es) Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas
BR112021017091A2 (pt) Célula microbiana geneticamente modificada, uso da referida célula, método para a produção fermentativa de um carboidrato de interesse e uso do mesmo
ECSP22051779A (es) Métodos para mejorar el cultivo celular con proteínas específicas de cada especie o específicas de cada género y las aplicaciones de los mismos
BR0311360A (pt) métodos para expansão e transdiferenciação in vitro de células acinares pancreáticas humanas em células produtoras de insulina
CL2022000449A1 (es) Método de producción de astaxantina mediante cultivo heterótrofo de haematococcus pluvialis
MX2017010859A (es) Metodo de fermentacion mixotrofica para poducir acetona, isopropanol, acido butirico y otros bioproductos, y mezclas de los mismos.
WO2021009777A3 (en) Methods of stem cell culture for obtaining products, and implementations thereof
PH12022550028A1 (en) Methods for growing african swine fever virus in fetal porcine lung alveolar macrophage cells
NO20064379L (no) Anvendelse av et serumfritt cellekulturmedium for produsjonen av IL-18BP i pattedyrceller
HRP20170216T1 (hr) Populacija ljudskih matičnih stanica vrata maternice i njihova uporaba
WO2021250583A3 (en) 3d culture of mesenchymal lineage precursor or stem cells
AR127140A1 (es) Método para la generación de estirpes celulares de macrófagos no transformados
CL2024001919A1 (es) Producción rápida de células t
MX2020013633A (es) Metodos para producir proteinas recombinantes.
AR123099A1 (es) Métodos de geminación de embriones
MX2025009917A (es) Metodos para generar celulas inmunitarias primarias
EP4635527A3 (en) Thymic constructs and uses thereof
AR131293A1 (es) Microorganismo para producir nucleótidos de purina y método para producir nucleótidos de purina usando los mismos
AR129895A1 (es) Método para producir partículas de aav recombinantes
BR112022005069A2 (pt) Vetores grandes e métodos para produção de alto rendimento
MX2023007480A (es) Sialiltransferasas para la producción de 6´-sialilactosa.